Journal of Pain and Symptom Management
Volume 31, Issue 2 , Pages 148-161 , February 2006

Supportive Intervention for Fatigue in Patients Undergoing Chemotherapy: A Randomized Controlled Trial

  • Emma Ream, PhD, MSc, BSc (Hons), RGN

      Affiliations

    • Corresponding Author InformationAddress reprint requests to: Emma Ream, PhD, Florence Nightingale School of Nursing & Midwifery, King's College London, 5th Floor Waterloo Bridge Wing, Franklin Wilkins Building, 150 Stamford Street, London, SE1 9NN, United Kingdom.
    • ,
  • Alison Richardson, PhD, MSc, BN (Hons), RGN
    • ,
  • Caroline Alexander-Dann, MSc, BSc, RGN

,Accepted 7 July 2005.

References 

  1. Sitzia J, Dikken C. Survey of the incidence and severity of side effects reported by patients receiving six cycles of FEC chemotherapy. J Cancer Nurs. 1997;1(2):61–73
  2. Stone P, Richardson A, Ream E, et al. Cancer-related fatigue: inevitable, unimportant and untreatable?. Ann Oncol. 2000;11:1–5
  3. Ream E, Richardson A. Fatigue in patients with cancer and chronic obstructive airways disease: a phenomenological enquiry. Int J Nurs Stud. 1997;34(1):44–53
  4. Ferrell B, Grant M, Dean G, Funk B, Ly J. Bone Tired: the experience of fatigue and its impact on quality of life. Oncol Nurs Forum. 1996;23(10):1539–1547
  5. Vogelzang N, Breitbart W, Cella D, et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. Semin Hematol. 1997;34(3 Suppl. 2):4–12
  6. Curt GA, Breitbart W, Cella D, et al. Impact of cancer-related fatigue on the lives of patients: new findings from the fatigue coalition. Oncologist. 2000;5(5):353–360
  7. Ream E, Browne N, Glaus A, Knipping C, Frei I. Quality and efficacy of educational materials on cancer-related fatigue: views of patients from two European countries. Eur J Oncol Nurs. 2003;7(2):99–109
  8. Barsevick A, Whitmer K, Walker L. In their own words: using the common sense model to analyze patient descriptions of cancer-related fatigue. Oncol Nurs Forum. 2001;28(9):1363–1369
  9. Hilfinger Messias D, Yeager K, Dibble S, Dodd M. Patients' perspectives of fatigue whilst undergoing chemotherapy. Oncol Nurs Forum. 1997;24(1):43–48
  10. Richardson A, Ream E. Self-care behaviours initiated by chemotherapy patients in response to fatigue. Int J Nurs Stud. 1997;34(1):35–43
  11. Bruera E, Roca E, Cedaro L. Action of oral methylprednisolone in terminal cancer patients: a randomised double-blind study. Cancer Treat Rep. 1985;69(7–8):751–754
  12. Robustelli Della Cuna G, Pellegrini A, Piazzi M. Effect of methylprednisolone sodium succinate on quality of life in pre-terminal cancer patients: a placebo-controlled, multicenter study. Eur J Cancer Clin Oncol. 1989;25(12):1817–1921
  13. Popiela T, Lucchi R, Giongo F. Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group. Eur J Cancer Clin Oncol. 1989;25(12):1823–1829
  14. Bruera E, Driver E, Barnes E, et al. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol. 2003;21(23):4439–4443
  15. Schwartz A, Thompson J, Masood N. Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate. Oncol Nurs Forum. 2002;29(7):E85–E90
  16. Rozans M, Dreisbach A, Lertora J, Hahn M. Palliative uses of methylphenidate in patients with cancer: a review. J Clin Oncol. 2002;20(1):335–339
  17. Bruera E, Strasser F, Shen L, et al. The effect of donepezil on sedation and other symptoms in patients receiving opioids for cancer pain: a pilot study. J Pain Symptom Manage. 2003;26(5):1049–1054
  18. Henry D, Abels R. Recombinant human erythropoietin in the treatment of cancer and chemotherapy induced anaemia: results of double-blind open-label follow-up studies. Semin Oncol. 1994;21(2 Suppl. 3):21–28
  19. Littlewood T, Bajetta E, Nortier J, Vercammen E, Rapoport B, Epoetin Alfa Study Group . Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2001;19(11):2865–2874
  20. Glaspy J, Bukowski R, Steinberg D, et al. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. J Clin Oncol. 1997;15(3):1218–1234
  21. Demetri G, Kris M, Wade J, Degos L, Cella D. Quality of life benefit in chemotherapy patients treated with Epoetin Alfa is independent of disease response or tumor type: results from a prospective study. J Clin Oncol. 1998;16(10):3412–3425
  22. MacVicar M, Winningham M, Nickel J. Effects of aerobic interval training on cancer patients' functional capacity. Nurs Res. 1989;38(6):348–351
  23. Segal R, Evans W, Johnson D, et al. Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomised controlled trial. J Clin Oncol. 2001;19(3):657–665
  24. Mock V, Hassey Dow K, Meares C, et al. Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum. 1997;24(6):991–1000
  25. Mock V, Pickett M, Ropka M, et al. Fatigue and quality of life outcomes of exercise during cancer treatment. Cancer Pract. 2001;9(3):119–127
  26. Dimeo F, Stieglitz R, Novelli-Flischer U, Fetscher S, Keul J. Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy. Cancer. 1999;85(10):2273–2277
  27. Porock D, Kristjanson L, Tinnelly K, Duke T, Blight J. An exercise intervention for advanced cancer patients experiencing fatigue: a pilot study. J Palliat Care. 2000;16(3):30–36
  28. Headley J, Ownby KK, John LD. The effect of seated exercise on fatigue and quality of life in women with advanced breast cancer. Oncol Nurs Forum. 2004;31(5):977–983
  29. Barsevick A, Dudley W, Beck S, et al. A randomized clinical trial of energy conservation for patients with cancer-related fatigue. Cancer. 2004;100(6):1302–1310
  30. Holley S, Borger D. Energy for living with cancer: preliminary findings of a cancer rehabilitation group intervention study. Oncol Nurs Forum. 2001;28(9):1393–1396
  31. Ream E, Richardson A, Alexander-Dann C. Facilitating patients' coping with fatigue during chemotherapy—pilot outcomes. Cancer Nurs. 2002;25(4):300–308
  32. Grant M, Golant M, Rivera L, Dean G, Benjamin H. Developing a community program on cancer pain and fatigue. Cancer Pract. 2000;8(4):187–194
  33. Given B, Given C, McCorkle R, et al. Pain and fatigue management: results of a nursing randomised clinical trial. Oncol Nurs Forum. 2002;29(6):949–956
  34. Given C, Given B, Rahbar M, et al. Effect of a cognitive behavioral Intervention on reducing symptom severity during chemotherapy. J Clin Oncol. 2004;22(3):507–516
  35. Newell S, Sanson-Fisher R, Savolainen N. Systematic review of psychological therapies for cancer patients and recommendations for future research. J Natl Cancer Inst. 2002;94(8):558–584
  36. Day S, Altman D. Blinding in clinical trials and other studies. BMJ. 2000;321(19–26):504
  37. Boutron I, Tubach F, Giraudeau B, Ravaud P. Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials. J Clin Epidemiol. 2004;57:543–550
  38. Schulz K. The landscape and lexicon of blinding in randomized trials. Ann Intern Med. 2002;136(3):254–259
  39. Patterson C, Dieppe P. Characteristic and incidental (placebo) effects in complex interventions such as acupuncture. BMJ. 2005;330(21 May):1201–1204
  40. Devereaux P, Manns B, Ghali W, et al. Physicians interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA. 2001;285(15):2000–2003
  41. Richardson A, Ream E, Wilson-Barnett J. Fatigue in patients receiving chemotherapy: patterns of change. Cancer Nurs. 1998;21(1):17–30[Erratum Cancer Nurs 1998;21(3):195]
  42. Aaronson L, Teel C, Cassmeyer V, et al. Defining and measuring fatigue. Image J Nurs Scholarsh. 1999;31(1):45–50
  43. Zigmond A, Snaith R. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–370
  44. Ware J, Snow K, Kosinski M, Gandek B. SF-36 Health Survey. Manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center; 1993;
  45. Carver C, Scheier M, Weintraub . Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol. 1989;56(2):267–283
  46. Winningham M. Fatigue. In:  Groenwald S,  Hansen Frogge M,  Goodman M,  Yarbro C editor. Cancer symptom management. Boston: Jones & Bartlett Publishers; 1996;p. 42–58
  47. Winningham M, Nail L, Barton Burke M, et al. Fatigue and the cancer experience: the state of the knowledge. Oncol Nurs Forum. 1994;21(1):23–36
  48. Courneya K, Mackey J, Jones L. Coping with cancer. Can exercise help?. Physician Sports Med. 2000;28(5):1–19
  49. Cimprich B, Ronis D. An environmental intervention to restore attention in women with newly diagnosed breast cancer. Cancer Nurs. 2003;26(4):284–292
  50. SPSS Inc . SPSS Data Analysis System. Release 11.0. Chicago, Illinois: SPSS Inc.; 2001;
  51. Carver C, Pozo C, Harris S, et al. How coping mediates the effect of optimism on distress: a study of women with early stage breast cancer. J Pers Soc Psychol. 1993;65(2):375–390
  52. Stone P, Ream E, Richardson A, et al. Cancer-related fatigue—a difference of opinion? Results of a multi centre survey of healthcare professionals, patients and caregivers. Eur J Cancer Care. 2002;12:20–27
  53. Lenz E, Pugh L, Milligan R, Gift A, Suppe F. The middle-range theory of unpleasant symptoms: an update. Adv Nurs Sci. 1997;19(3):14–27
  54. Holley S. Cancer-related fatigue. Suffering a different fatigue. Cancer Pract. 2000;8(2):87–95
  55. Cella D, Eton D, J-S L, Peterman A, Merkel D. Combining anchor and distribution-based methods to derive minimally clinically important differences on the functional assessment of cancer therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage. 2002;24(6):547–561
  56. Schwartz A, Meek P, Nail L, et al. Measurement of fatigue determining minimally important clinical differences. J Clin Epidemiol. 2002;55:239–244
  57. Barsevick A, Whitmer K, Sweeney C, Nail L. A pilot study examining energy conservation for cancer-treatment related fatigue. Cancer Nurs. 2002;25(5):333–341
  58. Devereaux P, Bhandari M, Montori V, et al. Double blind, you are the weakest link—goodbye!. Evid Based Nurs. 2002;5:36–37

 Caroline Alexander-Dann, our friend, colleague, and contributor to this paper, died on August 22, 2003.This project was supported by a Cancer Research Campaign Project Grant, number ce1162/0101.

PII: S0885-3924(06)00003-0

doi: 10.1016/j.jpainsymman.2005.07.003

Journal of Pain and Symptom Management
Volume 31, Issue 2 , Pages 148-161 , February 2006

Article Tools

* Image Usage & Resolution